Celcuity is a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies.
We: identify the signaling dysfunction driving a patient’s cancer that genetic tests cannot detect; directly measure the effectiveness of a targeted therapy in patient’s living tumor cells; confirm the therapeutic matching the patient’s cancer driver is present and functional in the cells before prescribing treatment, striving to improve the likelihood of a positive clinical outcome.
Source
